Thalassaemia in Singapore: Trait, Screening & What It Means

Written & reviewed by the BestDoctors.sg editorial team · Last updated 2 Sep 2026 · General information, not medical advice

The single most useful teaching point: small red cells (low MCV) with a normal ferritin – especially if iron tablets haven’t helped – should make you think thalassaemia trait, not just iron deficiency.

What thalassaemia is: alpha vs beta

Haemoglobin is made of protein chains – alpha and beta globin – and thalassaemia happens when the genes that direct these chains are altered, so the body produces less haemoglobin or a less effective form of it. In alpha thalassaemia the body makes too few alpha chains; in beta thalassaemia, too few beta chains. The result is red cells that are smaller and paler than normal and carry oxygen less efficiently, which shows up as anaemia of varying degree. How mild or severe this is depends on how many of the relevant genes are affected – ranging from a completely silent carrier state, through a mild trait, to serious disease. HbE is a related haemoglobin variant that is common across Southeast Asia and can combine with beta thalassaemia to produce a more significant condition, which is one reason the local picture differs from that of other regions.

The spectrum in plain terms: trait, intermediate and major

It helps to picture thalassaemia as a spectrum rather than a single illness. At one end is thalassaemia trait (also called minor or carrier state): a person inherits an altered gene from one parent, usually has only mildly small red cells, typically feels completely well and lives a normal life. Being a carrier is not a disease – it is a piece of genetic information that mostly matters for family planning and for avoiding unnecessary iron treatment. At the other end is thalassaemia major, inherited from both parents, in which severe anaemia appears in the first months or years of life and the child depends on lifelong, regular blood transfusions and specialist care. Between the two sit the intermediate forms, where anaemia is real and may need treatment at times but is less severe and less predictable than the major form. The crucial reassurance for the many people found to be carriers is simple: a trait and the disease are very different things.

Symptoms

Carriers usually have no symptoms at all, or at most a mild anaemia noticed only on a blood test. More significant thalassaemia, by contrast, can cause tiredness and low energy, pale skin, breathlessness on exertion, poor growth and delayed development in children, yellowing of the eyes or skin (jaundice) from the faster breakdown of red cells, and an enlarged spleen, which may cause abdominal fullness. Over time, both the anaemia itself and the treatments used for it can lead to further complications – for example, changes in the bones, gallstones, and the effects of iron building up in the body. These features are what prompt specialist assessment; a carrier with none of them need not worry about developing the severe disease later, because a trait does not turn into major.

Genetics and who is at risk

Thalassaemia is passed down through families: a child inherits one copy of each globin gene from each parent. If only one parent passes on an altered gene, the child is usually a carrier like that parent. If both partners carry a change in the same globin gene, each pregnancy carries a chance that the child could inherit a more severe form – which is exactly why carrier screening and genetic counselling are so valuable, particularly before or early in pregnancy. Carrying a trait is more common in people of certain ancestries here, including many Southeast-Asian, Chinese, Malay, Indian, Mediterranean and Middle-Eastern backgrounds, so a relevant family origin or a family history of anaemia or a haemoglobin disorder raises the value of getting tested. Because carriers so often feel well, family members frequently discover their status only when a relative is diagnosed or when a couple is screened.

The Singapore picture and why screening matters

Carrying a thalassaemia trait is relatively common in Singapore and the wider Southeast-Asian population, which is why the country runs an organised approach to detection through its National Thalassaemia Registry. The Registry supports carrier screening and genetic counselling, and subsidised testing is available to citizens and permanent residents through polyclinics, hospitals and GPs, with haematologists and centres such as KK Women’s and Children’s Hospital providing specialist input. Because two carriers of the same type have a real chance in each pregnancy of a child with a severe form, screening – ideally before pregnancy – lets couples understand their risk in advance and make informed choices with proper counselling. Reliable, plain-language information is also available through HealthHub, and screening fits naturally alongside premarital and antenatal check-ups, where it is often first offered.

Low MCV with a normal ferritin: think thalassaemia trait

Both iron deficiency and thalassaemia trait produce small red cells (a low MCV), so on a first glance they look alike. The distinction lies in the body’s iron stores: in iron deficiency the ferritin is low, whereas in thalassaemia trait the ferritin is normal or even high. This matters enormously in practice. If someone has small red cells but a normal ferritin – and especially if a course of iron tablets has not corrected the “anaemia” – thalassaemia trait should be considered and confirmed rather than assuming iron deficiency and simply repeating iron. Treating a carrier as though they were iron-deficient, when they are not, achieves nothing and can allow unnecessary iron to accumulate.

How thalassaemia is diagnosed

Testing usually starts with a full blood count, which shows the small red cells, together with iron studies and ferritin to separate it from iron deficiency. Confirmation comes from haemoglobin analysis (haemoglobin electrophoresis or HPLC), which measures the different types of haemoglobin present, and, where needed, genetic (DNA) testing to identify the precise change. Genetic testing is especially useful for accurate counselling and for alpha thalassaemia, which haemoglobin analysis alone can miss. Thalassaemia is often first picked up not because someone feels unwell but through routine screening, testing of relatives after a family member is diagnosed, or checks during pregnancy or premarital screening.

Treatment and management

Carriers usually need no treatment at all – only awareness. The key points for a carrier are to avoid taking iron supplements unless a doctor has confirmed genuine iron deficiency, and to consider genetic counselling, particularly before starting a family. Any unexplained anaemia deserves proper assessment rather than being treated automatically with iron. More severe thalassaemia, by contrast, is managed by a specialist haematology team and may involve regular blood transfusions to keep haemoglobin at a safe level, iron-removal treatment (chelation) to clear the excess iron that repeated transfusions cause – iron overload can otherwise damage the heart, liver and hormone glands – and folic acid to support red-cell production, alongside ongoing monitoring for complications. For selected patients, a bone-marrow or stem-cell transplant can be curative, and newer gene-based treatments are emerging; decisions about these are individual and made with the specialist team.

Living with thalassaemia

For those with more than a trait, life centres on regular specialist follow-up – keeping to the transfusion and chelation schedule, having complications monitored, and staying in touch with the haematology team so problems are caught early. Many people with well-managed thalassaemia lead full lives. For the far larger group who are simply carriers, living with the knowledge is mostly about passing it on sensibly: telling close relatives, who may wish to be screened, and mentioning the trait to any doctor so a mild anaemia is not repeatedly mistaken for iron deficiency.

Carrier screening and family planning

Screening is most useful before a couple starts a family. If both partners are carriers of the same type, a genetic counsellor can explain what this means for future pregnancies and set out the available options clearly and without pressure, so decisions are informed and personal. When a carrier couple is identified during pregnancy, counselling and testing can still be arranged. Because a trait so often runs quietly in a family, anyone found to carry it is encouraged to let siblings, parents and other close relatives know, since they may benefit from screening too.

When to see a doctor or get screened

Get checked if you have persistent mild anaemia or small red cells that iron doesn’t correct, if there’s a family history of thalassaemia or a haemoglobin disorder, or if you’re planning a pregnancy. Couples who are both carriers should seek genetic counselling. A haematologist and the National Thalassaemia Registry can confirm carrier status and advise.

Related blood & haematology topics

• Anaemia
• Iron-deficiency anaemia
• Vitamin B12 & folate deficiency
• G6PD deficiency
• Deep vein thrombosis (DVT)
• Low platelets (thrombocytopenia)
• Haemophilia
• Multiple myeloma
• Understanding your full blood count
• Pulmonary embolism
• Haematologists in Singapore
• Sickle Cell Disease
• Amniocentesis
• Blood Transfusion: What to Expect (Singapore)
• Pharmacogenomics in Singapore: Genes and Your Medicines
• Rare & Inherited Diseases in Singapore

Sources

• National Thalassaemia Registry (The Lancet Regional Health – Western Pacific) — Singapore carrier status, the screening programme and registry data.
• NHS — Thalassaemia: trait vs major, inheritance, diagnosis and treatment (transfusions, iron chelation).
• KK Women’s and Children’s Hospital / National Thalassaemia Registry — SG screening and genetic-counselling pathway.
• Annals Academy of Medicine Singapore — thalassaemia screening tests (FBC indices, haemoglobin analysis) in the SG context.